Medtronic acquires Influent Medical's Repose product line
31 December 2008
Medtronic, Inc. (NYSE: MDT) has acquired InfluENT Medical's Repose
GAHM product line for the treatment of obstructive sleep apnea (OSA).
The acquisition expands Medtronic's Surgical Technologies business unit
portfolio of treatments for sleep-disordered breathing.
Financial terms of the agreement were not disclosed.
The Repose Genioglossus Advancement and Hyoid Advancement (GAHA)
surgical devices advance the base of the tongue and the hyoid bone to
prevent obstructions of the airway during sleep. In addition to the
Repose System, the Surgical Technologies business of Medtronic offers
the Pillar Palatal Implant System, used to treat the soft palate
component of sleep breathing disorders, and an existing family of
market-leading ENT instruments used to treat other upper airway
“The Repose GAHM devices provide our surgeon customers with another
minimally invasive, low morbidity option to treat patients suffering
from OSA,” said Bob Blankemeyer, president of the Surgical Technologies
business and senior vice president at Medtronic.
Bookmark this page